Vanguard Global Advisers »

Neuropace shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $131k 10k 13.15

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Neuropace

Soleus Capital Management
Polar Capital Holdings
Morgan Stanley
First Light Asset Management
BlackRock
OrbiMed Advisors
Driehaus Capital Management
Vanguard Group
Vanguard Capital Management
Deutsche Bank Aktiengesellschaft
Armistice Capital
FMR
Geode Capital Management
State Street Corporation
Silvercrest Asset Management Group

View all funds holding Neuropace